Literature DB >> 20019687

Kinase mutations in human disease: interpreting genotype-phenotype relationships.

Piya Lahiry1, Ali Torkamani, Nicholas J Schork, Robert A Hegele.   

Abstract

Protein kinases are one of the largest families of evolutionarily related proteins and comprise one of the most abundant gene families in humans. Here we survey kinase gene mutations from the perspective of human disease phenotypes and further analyse the structural features of mutant kinases, including mutational hotspots. Our evaluation of the genotype-phenotype relationship across 915 human kinase mutations - that underlie 67 single-gene diseases, mainly inherited developmental and metabolic disorders and also certain cancers - enhances our understanding of the role of kinases in development, kinase dysfunction in pathogenesis and kinases as potential targets for therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20019687     DOI: 10.1038/nrg2707

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN: 1471-0056            Impact factor:   53.242


  118 in total

1.  Scythe regulates apoptosis-inducing factor stability during endoplasmic reticulum stress-induced apoptosis.

Authors:  Fabienne Desmots; Helen R Russell; Denis Michel; Peter J McKinnon
Journal:  J Biol Chem       Date:  2007-12-03       Impact factor: 5.157

2.  Phenomics, lamin A/C, and metabolic disease.

Authors:  Robert A Hegele
Journal:  J Clin Endocrinol Metab       Date:  2007-12       Impact factor: 5.958

3.  The second wave in kinase cancer drugs.

Authors:  Ken Garber
Journal:  Nat Biotechnol       Date:  2006-02       Impact factor: 54.908

Review 4.  Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

Authors:  Gary L Johnson; Razvan Lapadat
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

5.  Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension.

Authors:  Wai K P Wong; James A Knowles; Jane H Morse
Journal:  Am J Respir Cell Mol Biol       Date:  2005-07-07       Impact factor: 6.914

6.  Variant between CPT1B and CHKB associated with susceptibility to narcolepsy.

Authors:  Taku Miyagawa; Minae Kawashima; Nao Nishida; Jun Ohashi; Ryosuke Kimura; Akihiro Fujimoto; Mihoko Shimada; Shinichi Morishita; Takashi Shigeta; Ling Lin; Seung-Chul Hong; Juliette Faraco; Yoon-Kyung Shin; Jong-Hyun Jeong; Yuji Okazaki; Shoji Tsuji; Makoto Honda; Yutaka Honda; Emmanuel Mignot; Katsushi Tokunaga
Journal:  Nat Genet       Date:  2008-09-28       Impact factor: 38.330

7.  Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome.

Authors:  A O Wilkie; S F Slaney; M Oldridge; M D Poole; G J Ashworth; A D Hockley; R D Hayward; D J David; L J Pulleyn; P Rutland
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

8.  Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells.

Authors:  Frédéric Pouliot; Alexandre Blais; Claude Labrie
Journal:  Cancer Res       Date:  2003-01-15       Impact factor: 12.701

Review 9.  What's new in the neuro-cardio-facial-cutaneous syndromes?

Authors:  Ellen Denayer; Eric Legius
Journal:  Eur J Pediatr       Date:  2007-07-05       Impact factor: 3.183

10.  Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis.

Authors:  Robert K Semple; Alison Sleigh; Peter R Murgatroyd; Claire A Adams; Les Bluck; Sarah Jackson; Alessandra Vottero; Dipak Kanabar; Valentine Charlton-Menys; Paul Durrington; Maria A Soos; T Adrian Carpenter; David J Lomas; Elaine K Cochran; Phillip Gorden; Stephen O'Rahilly; David B Savage
Journal:  J Clin Invest       Date:  2009-01-26       Impact factor: 14.808

View more
  134 in total

1.  Cancer risk among patients with myotonic muscular dystrophy.

Authors:  Shahinaz M Gadalla; Marie Lund; Ruth M Pfeiffer; Sanne Gørtz; Christine M Mueller; Richard T Moxley; Sigurdur Y Kristinsson; Magnus Björkholm; Fatma M Shebl; James E Hilbert; Ola Landgren; Jan Wohlfahrt; Mads Melbye; Mark H Greene
Journal:  JAMA       Date:  2011-12-14       Impact factor: 56.272

2.  Opportunities and challenges for nutritional proteomics in cancer prevention.

Authors:  Donato F Romagnolo; John A Milner
Journal:  J Nutr       Date:  2012-05-30       Impact factor: 4.798

Review 3.  Recent Advances and New Strategies in Targeting Plk1 for Anticancer Therapy.

Authors:  Kyung S Lee; Terrence R Burke; Jung-Eun Park; Jeong K Bang; Eunhye Lee
Journal:  Trends Pharmacol Sci       Date:  2015-10-17       Impact factor: 14.819

4.  HPLC-UV method for simultaneous determination of MK-1775 and AZD-7762 in both acetonitrile-aqueous solution and mouse plasma.

Authors:  Kareem Ebeid; Giang N Ho; Aliasger K Salem
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-12-30       Impact factor: 3.205

5.  CBL mutations in myeloproliferative neoplasms are also found in the gene's proline-rich domain and in patients with the V617FJAK2.

Authors:  Paula Aranaz; Cristina Hurtado; Ignacio Erquiaga; Itziar Miguéliz; Cristina Ormazábal; Ion Cristobal; Marina García-Delgado; Francisco Javier Novo; José Luis Vizmanos
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

6.  A subcellular map of the human kinome.

Authors:  Haitao Zhang; Xiaolei Cao; Mei Tang; Guoxuan Zhong; Yuan Si; Haidong Li; Feifeng Zhu; Qinghua Liao; Liuju Li; Jianhui Zhao; Jia Feng; Shuaifeng Li; Chenliang Wang; Manuel Kaulich; Fangwei Wang; Liangyi Chen; Li Li; Zongping Xia; Tingbo Liang; Huasong Lu; Xin-Hua Feng; Bin Zhao
Journal:  Elife       Date:  2021-05-14       Impact factor: 8.140

7.  The Role of Regulatory Domains in Maintaining Autoinhibition in the Multidomain Kinase PKCα.

Authors:  Ruth F Sommese; Michael Ritt; Carter J Swanson; Sivaraj Sivaramakrishnan
Journal:  J Biol Chem       Date:  2017-01-03       Impact factor: 5.157

8.  Lowering Sample Requirements to Study Tyrosine Kinase Signaling Using Phosphoproteomics with the TMT Calibrator Approach.

Authors:  Bin Fang; Victoria Izumi; Lily L Remsing Rix; Eric Welsh; Ian Pike; Gary W Reuther; Eric B Haura; Uwe Rix; John M Koomen
Journal:  Proteomics       Date:  2020-09-30       Impact factor: 3.984

9.  The human kinome and kinase inhibition.

Authors:  Krisna C Duong-Ly; Jeffrey R Peterson
Journal:  Curr Protoc Pharmacol       Date:  2013-03

Review 10.  Receptor tyrosine kinase mutations in developmental syndromes and cancer: two sides of the same coin.

Authors:  Laura M McDonell; Kristin D Kernohan; Kym M Boycott; Sarah L Sawyer
Journal:  Hum Mol Genet       Date:  2015-07-07       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.